Impact Factor
3.14
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.36
317 total citations
h5-index
21
h5 depth signal
Cited share
70.1%
96 of 137
Total citations
317
Citation footprint
Metric signal
2.31
External metric anchor
Self-citation
4.1%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
581
Canada
44
United Kingdom
38
Italy
33
Germany
23
Citing Fields of Research
Transplantation
725
Immunology
60
Liver Diseases
60
Kidney Diseases
40
Digestive Disorders
40
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,613
Articles tracked across the journal lifetime
Indexed publication set
137
96 cited publications
Last 12 months
57
4.8 publications/month
Open access share
10.5%
6 OA publications in the last year
Leading citing country
United States
581 citing publications
Leading citing field
Transplantation
725 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v13n1, Feb. 2008-
v13n1, Feb. 2008-
Research Focus & Classification
Indexed Subjects
Transplantation
Broad Categories
Transplantation
MeSH Descriptors
Immunosuppression Therapy.
Organ Transplantation
Transplantation Immunology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/mot.0000000000001319
Open DOI
Genetic evaluation in living liver donors: beyond individual risk to system responsibility
Purpose of review: Living donor liver transplantation (LDLT) increasingly depends on biologically related donors, particularly in Asia and the Middle East, where deceased donation remains limited. This review evaluates genetic risks in l...
02
DOI 10.1097/mot.0000000000001316
Open DOI
GWAS studies and polygenic risk scores in organ transplantation
Purpose of review: To summarize recent developments published between 1 January 2024 and 15 August 2026 in genome-wide and polygenic analyses of solid organ transplantation, with a focus on kidney, heart, liver, and lung transplantation....
03
DOI 10.1097/mot.0000000000001312
Open DOI
Management of patients with cardiopulmonary comorbidities awaiting liver transplantation
Purpose of review: The need for liver transplant continues to rise especially among those with metabolic dysfunction associated steatotic liver disease. Consequently, more transplant candidates have concurrent cardiopulmonary comorbiditi...
04
DOI 10.1097/mot.0000000000001314
Open DOI
Gut microbial metabolism of immunosuppressive drugs: from metagenomic associations to functional enzyme biomarkers
Purpose of review: Inter-individual variability in immunosuppressant exposure remains a major challenge in transplantation. Pharmacogenomics and host-related factors contribute to this variability, with increasing evidence suggesting tha...
05
DOI 10.1097/mot.0000000000001311
Open DOI
Critical care aspects of the patient awaiting liver transplantation
Purpose of review: The indications for liver transplantation have continued to evolve and now extend beyond elective transplantation for decompensated cirrhosis and emergency liver transplantation for acute liver failure (ALF), to patien...
06
DOI 10.1097/mot.0000000000001307
Open DOI
Editorial introductions
Was not provided for this article.
07
DOI 10.1097/mot.0000000000001301
Open DOI
Immunosuppression in vascularized composite allotransplantation
Purpose of review: Vascularized composite allotransplantation (VCA) restores form and function after disfiguring tissue loss with the required need for lifelong immunosuppression for a non-life-saving indication, creating a distinct risk...
08
DOI 10.1097/mot.0000000000001309
Open DOI
Precision monitoring of kidney transplant health via cell-free DNA and RNA
Purpose of review: Cell-free nucleic acids (cfNAs) in plasma and urine have emerged as noninvasive biomarkers for monitoring kidney transplant health. This review summarizes recent advances in the development of cell-free DNA (cfDNA) and...
09
DOI 10.1097/mot.0000000000001305
Open DOI
Gut microbiota and complications in kidney transplantation: a balancing act between commensal and pathogenic bacteria
Purpose of review: Recent work has linked gut dysbiosis, an imbalance of commensal and pathogenic bacteria, to complications in kidney transplant recipients. The purpose of this review is to evaluate the gut microbiota's relationship to ...
10
DOI 10.1097/mot.0000000000001308
Open DOI
Pain syndromes in transplantation: the role of the gut microbiome
Purpose of review: The purpose of this review is to discuss common pain phenotypes in transplantation, summarize known gut microbiome features associated with chronic pain, and to map known gut microbiome features in transplantation with...
Bibliographical & Catalog Notes
Place of publication varies.
Description based on: Vol. 2, no. 1 (Oct. 1997); title from cover.
Also issued online.